Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?

被引：75
作者：
Gauci, Marie-Lea [1 ,2 ]
Baroudjian, Barouyr [1 ,2 ]
Zeboulon, Charlotte [1 ,2 ]
Pages, Cecile [1 ,2 ]
Pote, Nicolas [3 ,4 ]
Roux, Olivier [5 ]
Bouattour, Mohamed [6 ]
Lebbe, Celeste [1 ,2 ]
机构：
[1] Hop St Louis, AP HP, Dept Dermatol, Paris, France
[2] Univ Paris Diderot Paris VII, Sorbonne Paris Cite, INSERM U976, Paris, France
[3] Hop Beaujon, AP HP, Dept Anatomopathol, Clichy, France
[4] Univ Paris Diderot Paris VII, Sorbonne Paris Cite, INSERM UMR 1149, Paris, France
[5] Hop Beaujon, AP HP, Dept Hepatol & Reanimat Hepat, Clichy, France
[6] Hop Beaujon, AP HP, Dept Oncol Digest, 100 Blvd Gen Leclerc, F-92110 Clichy, France
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 69卷 / 02期
关键词：
IPILIMUMAB; NIVOLUMAB;
D O I：
10.1016/j.jhep.2018.03.034
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：548 / 550
页数：4
相关论文
共 50 条
  • [21] Identification of immune-related subtypes of colorectal cancer to improve antitumor immunotherapy
    Zheng, Xiaobo
    Gao, Yong
    Yu, Chune
    Fan, Guiquan
    Li, Pengwu
    Zhang, Ming
    Yu, Jing
    Xu, Mingqing
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [22] Immune-Related Thyroiditis with Immune Checkpoint Inhibitors
    Iyer, Priyanka C.
    Cabanillas, Maria E.
    Waguespack, Steven G.
    Hu, Mimi I.
    Thosani, Sonali
    Lavis, Victor R.
    Busaidy, Naifa L.
    Subudhi, Sumit K.
    Diab, Adi
    Dadu, Ramona
    THYROID, 2018, 28 (10) : 1243 - 1251
  • [23] Response criteria for immunotherapy and the radiologic patterns of immune-related adverse events
    Elsherif, Sherif B.
    Anderson, Marcus
    Chaudhry, Ammar A.
    Kumar, Sindhu P.
    Gopireddy, Dheeraj R.
    Lall, Chandana
    Bhosale, Priya R.
    EUROPEAN JOURNAL OF RADIOLOGY, 2022, 146
  • [24] Immune-related adverse events are associated with therapeutic efficacy of immunotherapy in patients with melanoma brain metastases
    Huo, Cecilia W.
    Gunadasa, Indika
    Gkolia, Panagiota
    Shackleton, Mark
    Hunn, Martin
    MELANOMA RESEARCH, 2023, 33 (01) : 58 - 65
  • [25] Interleukin-6 blockade for prophylaxis and management of immune-related adverse events in cancer immunotherapy
    Dimitriou, Florentia
    Hogan, Sabrina
    Menzies, Alexander M.
    Dummer, Reinhard
    Long, Georgina, V
    EUROPEAN JOURNAL OF CANCER, 2021, 157 : 214 - 224
  • [26] The evolving role of the rheumatologist in the management of immune-related adverse events (irAEs) caused by cancer immunotherapy
    Calabrese, Leonard
    Mariette, Xavier
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (02) : 162 - 164
  • [27] Immune-related adverse events as predictors of response in cancer patients undergoing immunotherapy
    Ezponda Casajus, A.
    Calvo Imirizaldu, M.
    de Torres Tajes, J. P.
    Garcia-Baizan, A.
    Castanon Alvarez, E.
    Cano Rafart, D.
    Vivas Perez, I
    Bastarrika Aleman, G.
    RADIOLOGIA, 2020, 62 (02): : 131 - 138
  • [28] Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC
    Santini, Fernando C.
    Rizvi, Hira
    Plodkowski, Andrew J.
    Ni, Andy
    Lacouture, Mario E.
    Gambarin-Gelwan, Maya
    Wilkins, Olivia
    Panora, Elizabeth
    Halpenny, Darragh F.
    Long, Niamh M.
    Kris, Mark G.
    Rudin, Charles M.
    Chaft, Jamie E.
    Hellmann, Matthew D.
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09) : 1093 - 1099
  • [29] Balancing Tumor Immunotherapy and Immune-Related Adverse Events: Unveiling the Key Regulators
    Huang, Jianshang
    Xiong, Lei
    Tang, Sainan
    Zhao, Junhao
    Zuo, Li
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (20)
  • [30] Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management (Review)
    Stucci, Stefania
    Palmirotta, Raffaele
    Passarelli, Anna
    Silvestris, Erica
    Argentiero, Antonella
    Lanotte, Laura
    Acquafredda, Silvana
    Todisco, Annalisa
    Silvestris, Franco
    ONCOLOGY LETTERS, 2017, 14 (05) : 5671 - 5680
12345